Continuous glucose monitoring (CGM) in hospitalized patients was superior to point-of-care (POC) testing for maintaining healthy glycemic levels in the inpatient setting, according to a report that ...
Point-of-care testing for glycated haemoglobin (HbA1c) has emerged as a transformative tool in the management of diabetes, enabling clinicians to obtain near-immediate feedback on average glycaemic ...
The global point of care testing market is projected to grow from USD 42 billion in 2025 to USD 64.8 billion by 2031, ...
A shoebox-sized optical device reads glucose directly through the skin in seconds, offering a promising step toward truly noninvasive, point-of-care glucose monitoring. Pipeline for the development of ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. First, let me ...
This webinar's emphasis on CLIA quality standards and the integration of Integri-sense Technology within RAPIDPoint® 500e System seeks to illuminate the path toward enhanced quality management at the ...
The global point of care testing market is projected to grow from USD 42 billion in 2025 to USD 64.8 billion by 2031, registering a CAGR of 7.5% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results